Biogen CEO 'reasonably confident' once-doomed Alzheimer's drug will be granted FDA approvalCNBC • 10/23/19
Biogen Inc. (BIIB) CEO Michel Vounatsos on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 10/22/19
Biogen's stock surge increases value of recent stock repurchased by over $700 millionMarket Watch • 10/22/19
Biogen Stock Rockets On Plans To Seek Approval For Alzheimer's DrugInvestors Business Daily • 10/22/19
Biogen's stock soars toward record rally, set to add nearly $17 billion to market capMarket Watch • 10/22/19